These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28608547)

  • 1. Computational modeling of the bat HKU4 coronavirus 3CL
    Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS).
    St John SE; Tomar S; Stauffer SR; Mesecar AD
    Bioorg Med Chem; 2015 Sep; 23(17):6036-48. PubMed ID: 26190463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.
    Xia S; Lan Q; Pu J; Wang C; Liu Z; Xu W; Wang Q; Liu H; Jiang S; Lu L
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30646495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Bat Coronaviruses in South China That Use the Same Receptor as Middle East Respiratory Syndrome Coronavirus.
    Luo CM; Wang N; Yang XL; Liu HZ; Zhang W; Li B; Hu B; Peng C; Geng QB; Zhu GJ; Li F; Shi ZL
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of MERS coronavirus-like viruses in bats: pote1ntial for tracking MERS coronavirus transmission and animal origin.
    Woo PCY; Lau SKP; Chen Y; Wong EYM; Chan KH; Chen H; Zhang L; Xia N; Yuen KY
    Emerg Microbes Infect; 2018 Mar; 7(1):18. PubMed ID: 29511173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and full genome characterization of two beta CoV viruses related to Middle East respiratory syndrome from bats in Italy.
    Moreno A; Lelli D; de Sabato L; Zaccaria G; Boni A; Sozzi E; Prosperi A; Lavazza A; Cella E; Castrucci MR; Ciccozzi M; Vaccari G
    Virol J; 2017 Dec; 14(1):239. PubMed ID: 29258555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors.
    Kumar V; Tan KP; Wang YM; Lin SW; Liang PH
    Bioorg Med Chem; 2016 Jul; 24(13):3035-3042. PubMed ID: 27240464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV).
    Dampalla CS; Miller MJ; Kim Y; Zabiegala A; Nguyen HN; Madden TK; Thurman HA; Machen AJ; Cooper A; Liu L; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2023 Jun; 254():115376. PubMed ID: 37080108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26.
    Wang Q; Qi J; Yuan Y; Xuan Y; Han P; Wan Y; Ji W; Li Y; Wu Y; Wang J; Iwamoto A; Woo PC; Yuen KY; Yan J; Lu G; Gao GF
    Cell Host Microbe; 2014 Sep; 16(3):328-37. PubMed ID: 25211075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling.
    Lee H; Ren J; Pesavento RP; Ojeda I; Rice AJ; Lv H; Kwon Y; Johnson ME
    Bioorg Med Chem; 2019 May; 27(10):1981-1989. PubMed ID: 30940566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element.
    Galasiti Kankanamalage AC; Kim Y; Damalanka VC; Rathnayake AD; Fehr AR; Mehzabeen N; Battaile KP; Lovell S; Lushington GH; Perlman S; Chang KO; Groutas WC
    Eur J Med Chem; 2018 Apr; 150():334-346. PubMed ID: 29544147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
    Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
    PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
    Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
    J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
    Needle D; Lountos GT; Waugh DS
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1102-11. PubMed ID: 25945576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.
    Olubiyi OO; Olagunju M; Keutmann M; Loschwitz J; Strodel B
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32668701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases.
    Kumar V; Roy K
    SAR QSAR Environ Res; 2020 Jul; 31(7):511-526. PubMed ID: 32543892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.